Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)
Clinical trial NCT04918147 · TERMINATED
Trial details
- NCT number
- NCT04918147
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-13
- Primary completion
- 2024-01-04
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.